Väntar sig patent

Follicum får preliminärt godkännande från Europapatentverket.

Designar alternativ till antibiotika

Martina Kulén, Kemiska institutionen, Umeå universitet, har i sitt avhandlingsarbete arbetat med utveckling av antivirulens-molekyler mot två olika bakterier.

Gedea får Horizon-pengar

Vill bli alternativ till antibiotika – Hoppas nå marknaden 2021.

International models among science parks

Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...

New faces in Pronova Biopharma team

The Norwegian company Pronova Biopharma has recently changed the management team structure.

”Vi hanterar morgondagens problem”

Samarbeten mellan akademi och företag kan tydliggöra värdet av att arbeta inom labtech och diagnostik för studenter, enligt en av deltagarna i en paneldiskussion.

Early stage research and low turnaround dominates

Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...

Torgny Fornstedt: Analytisk kemi måste hitta tillbaka till sina rötter

Det behövs fler kunniga analytiska kemister både på universiteten och inom industrin, skriver Torgny Fornstedt i en krönika.

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

Protein match-maker

Professor Sophia Hober har fler järn i elden än de flesta. Hon är en av de mest framträdande forskarna i den viktiga kartläggningen av människans proteiner. Pro...

EU says yes to Roche drug

EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.

Ryssland satsar på klinisk forskning

Ryska Quintiles och statlig kapitalfond samarbetar i ny hälsoplan som ska sätta landets kliniska forskning på världskartan.

Future drugs from Amaryllis

A Danish research team has discovered possibolities to extract drugs fro Amaryllis.

Blood type decide resistance to HIV

A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.

New CEO to Swedish Tillotts Pharma

The Swiss company Tillotts Pharma's newly established Swedish organisation has appointed a CEO from Bayer Scandinavia.

Respiratorius hunts millions

The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

LEO Pharma - International Clinical Trial Manager

Hon skrev bästa avhandlingen

”En doktorsavhandling av hög kvalitet som uppvisar en utmärkt förmåga att kommunicera vetenskap och resultat.” Så löd motiveringen när Rosenön Award delades ut.

DKK 1,3 billion for grand research

Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.